Clinical trials
Phase 2 Mycoses trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
9 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2009 | 2 |
| 2014 | 1 |
| 2016 | 2 |
| 2018 | 1 |
| 2020 | 1 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 6 |
| Terminated | 2 |
| Recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Cidara Therapeutics Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) | 2 |
| Basilea Pharmaceutica | 1 |
| M.D. Anderson Cancer Center | 1 |
| National Institute of Allergy and Infectious Diseases (NIAID) | 1 |
| Nohla Therapeutics, Inc. | 1 |
| Scynexis, Inc. | 1 |
| Stanford University | 1 |
| The University of Queensland | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Mycoses | 9 |
| Aspergillosis | 2 |
| Candidemia | 2 |
| Candidiasis, Invasive | 2 |
| Bacterial Infections | 1 |
| Bone Marrow Neoplasms | 1 |
| COVID-19 | 1 |
| Candidiasis, Vulvovaginal | 1 |
| Communicable Diseases | 1 |
| Fungemia | 1 |
Trials
Showing 1 to 9 of 9. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.